$1.80
-0.01 (-0.55%)
ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)
CAPS Rating:
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.
RSS Headlines
Fool UK